VAY736, TENOFOVIR ALAFENAMIDE, ENTECAVIR , -, VAY736, VAY736, TENOFOVIR DISOPROXIL
CVAY736A2202
Phase 2 small_molecule active
Quick answer
VAY736, TENOFOVIR ALAFENAMIDE, ENTECAVIR , -, VAY736, VAY736, TENOFOVIR DISOPROXIL for Rheumatoid Arthritis, Sjögren’s Disease, Systemic Lupus erythematosus is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Rheumatoid Arthritis, Sjögren’s Disease, Systemic Lupus erythematosus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active